GC Biopharma and Hanmi Pharm export next-generation Fabry disease drug technology
Predicted impact: Medium
Next-gen Fabry technology export; likely the same deal as the ₩640B item.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.